TX HB4586

Prohibits all direct-to-consumer pharmaceutical advertising within Texas, covering promotional communications for prescription drugs across television, radio, print media, digital platforms, and social media

Authorizes the department to assess administrative penalties of up to $10,000 per day for each violation, with each day of continued violation counted as a separate offense

Grants the executive commissioner authority to adopt rules necessary to implement the advertising prohibition

Amends Chapter 431 of the Health and Safety Code by adding Section 431.118

Effective date: September 1, 2025